- Opening remarks
- Barriers and challenges with HF treatment optimization
- Recent safety and efficacy data for current and emerging treatment initiation during or following a hospitalization for HF
- Strategies to improve transitions of care
- Closing remarks
- Question and answer session
Date / Time
Javed Butler, MD, MPH, MBA
Baylor Scott and White Research Institute
Distinguished Professor of Medicine
University of Mississippi
Michelle Kittleson, MD, PhD
Professor of Medicine
Department of Cardiology
Smidt Heart Institute
Cedars-Sinai Medical Center
Los Angeles, California
Expert faculty will discuss the importance of optimizing guideline-recommended treatment in patients with heart failure at transitions of care.
The goal of this program is to improve the knowledge and competence of cardiology, internal medicine, and family medicine providers (including physicians, nurse practitioners, and physician associates/physician assistants), pharmacists, and other healthcare professionals who manage patients with HF to optimize HF management at care transitions.
The program is intended for cardiologists, internal medicine, and family medicine providers (including physicians, nurse practitioners, and physician associates/physician assistants); and pharmacists who manage patients with HF.
- Compare the risks and benefits of optimizing guideline-directed medical therapy during a hospitalization for HF
- Evaluate recent clinical trial efficacy and safety data for HF treatment initiation in patients currently or recently hospitalized for HF
- Incorporate best practices for the management of patients with HF during transitions of care
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation:
The University of Cincinnati designates this webcast activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour, including 1.0 hour of pharmacology credit.
Physician Assistant/Physician Associate Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
In accordance with the ACCME Standards for Integrity and Independence Integrity in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education, or whose conflicts of interests cannot be mitigated.
*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.